Clinical Trials Logo

Clinical Trial Summary

The goal of this clinical trial study is to(1) determine the tissue specific dose of I-131 taken up by residing thyroid issue in the thyroid bed post-RAI along with any other sites in the neck and mediastinum as well as (2) correlate the dose delivered to residual tissues in the neck with patient follow-up based clinical outcomes, biochemical and imaging data following RAI therapy in patients with well-differentiated thyroid cancer (DTC). The main question[s] it aims to answer are: - [question 1] How can obtained whole body and planar images more adequately depict residual iodine-avid disease in the thyroid bed, neck or mediastinum? - [question 2] How can we obtain information on the dose taken up by the tumor remnant to know how much radionuclide actually went to the residual disease/tissue? Participants will [describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items].


Clinical Trial Description

In our current clinical practice, patients with well-differentiated thyroid cancer (DTC) who receive oral administration of radioiodine 1-131 (RAI) have whole body and planar images obtained 4-5 days post-treatment. These images often do not adequately depict residual iodine-avid disease in the thyroid bed, neck or mediastinum. Further, no information about what dose taken up by the tumor remnant is obtained and thus we are unable to know how much radionuclide actually went to the residual disease/tissue. Using single photon emission computed tomography (SPECT)/CT we will be able to better localize and evaluate disease/tissue remnant or distant iodine-avid metastatic disease. In addition, using Varian Velocity Theranostics Dosimetry suite of software applications, we will be able to do dosimetry on post-RAI therapy patients and be able to better correlate clinical outcomes with tumor absorbed dose in addition to provide quality improvement for the radioiodine ablation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06028282
Study type Observational [Patient Registry]
Source State University of New York - Upstate Medical University
Contact
Status Enrolling by invitation
Phase
Start date November 8, 2021
Completion date June 8, 2025

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05836246 - The Development of Quantitative Ultrasound Imaging Software Platform
Active, not recruiting NCT05579782 - Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy N/A
Completed NCT04124705 - A Study of Armour® Thyroid Compared to Synthetic T4 (Levothyroxine) in Previously Hypothyroid Participants Phase 2
Recruiting NCT05626010 - Efficacy of Acetaminophen-ibuprofen Combination on the Postoperative Pain After Thyroidectomy N/A
Completed NCT01805856 - Antimicrobial Prophylaxis in Thyroid and Parathyroid Surgery N/A
Completed NCT03640247 - Pain Medications Following Thyroidectomy and Parathyroidectomy Phase 1
Recruiting NCT05117853 - Autofluorescence and Indocyanine Green to Avoid Hypocalcemia After Thyroidectomy Phase 3
Completed NCT00592605 - Thyroid Disease Serum Repository N/A
Completed NCT04344886 - Optimization and Individualization of Diagnostic Scintigraphy Protocol and Minimally Invasive Radio-guided Parathyroid Surgery N/A
Completed NCT03012438 - NIRF for Parathyroid Visualization: a Pilot Study N/A
Completed NCT00846755 - Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening N/A
Completed NCT04635813 - The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study
Not yet recruiting NCT05432050 - Bispectral Index and Patient State Index During General Anesthesia With Remimazolam
Recruiting NCT03191188 - A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients N/A
Recruiting NCT06296420 - Dysphagia After Thyroidectomy
Completed NCT02981095 - Effect of Bupivacaine Application on Postthyroidectomy Pain N/A
Completed NCT01539499 - Complications of Endocrine Surgery: Data From the United HealthSystem Consortium N/A
Completed NCT05421559 - Transection of Sternothyroid Muscle Increases the Rate of Exposure of the External Laryngeal Nerve During Thyroidectomy N/A
Completed NCT00054756 - Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities Phase 2
Completed NCT02951000 - Platysma Trial - Platysma Suturing Versus no Sutures for Wound Closure After Primary Thyroid Surgery N/A